Results 191 to 200 of about 19,494 (244)

Metabolomics-Based Analysis Linking Oxidative Stress-Related Branched-Chain Amino Acid (BCAA) Pathway with Atopic Indices to Childhood Allergies. [PDF]

Antioxidants (Basel)
Ku JL, Su KW, Chiang MH, Kuo CN, Yeh KW, Huang JL, Chiu CY.   +6 more
europepmc   +1 more source

When biomarkers disagree: interpreting <i>F</i>eNO and eosinophils across airway disease. [PDF]

Thorax
Almansa-López A, Romero-Palacios PJ, Alcazar Navarrete B.   +2 more
europepmc   +1 more source

Disparities in Cough Variant Asthma Management and Physician-Reported Pulmonary Function Testing Resources: A Cross-Sectional Survey of Respiratory Physicians Across Hospital Tiers in Zhejiang, China. [PDF]

J Asthma Allergy
Guo J, Zhang X, Lai J, Wang J, Shen L, Zhong Y, Huang H.   +6 more
europepmc   +1 more source

Feno-klimatologisch onderzoek aan stamslabonen

, 1958
Post, J.J., Groenewegen, J.H.
openaire   +1 more source

Update on the Role of FeNO in Asthma Management [PDF]

Diagnostics, 2023
Asthma is a heterogenous disorder characterized by presence of different phenotypes and endotypes. Up to 10% of the individuals suffer from severe asthma and are at increased risk of morbidity and mortality. Fractional exhaled nitric oxide (FeNO) is a cost-effective, point of care biomarker that is used to detect type 2 airway inflammation.
Muhammad Adrish, Nicola Hanania, Damini Saxena   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

FeNO in Asthma

Seminars in Respiratory and Critical Care Medicine, 2022
AbstractAsthma is a common disease affecting 350 million people worldwide, which is characterized by airways inflammation and hyperreactivity. Historically diagnosis and treatment have been mainly based on symptoms, which have the potential to result in misdiagnosis and inappropriate treatment.
Lola, Loewenthal, Andrew, Menzies-Gow
openaire   +2 more sources

A pathophysiological approach for FeNO: A biomarker for asthma

Allergologia Et Immunopathologia, 2015
The present review is focused on literature concerning the relevance of fractional exhaled nitric oxide (FeNO) in clinical practice from a pathophysiological point of view. There is increasing evidence that asthma is a heterogeneous pathological condition characterised by different phenotypes/endotypes related to specific biomarkers, including FeNO ...
Giorgio Ciprandi, Fabio Luigi Massimo Ricciardolo   +1 more
exaly   +3 more sources

FeNO as biomarker for asthma phenotyping and management

Allergy and Asthma Proceedings, 2015
The current review aims to revisit literature on exhaled nitric oxide (FeNO) in asthma phenotyping and management to clarify the utility of this test in clinical practice. It is increasingly evident that multiple profiles characterize asthma as a complex disease for which is necessary to find tools able to discriminate among these phenotypes to achieve
Giorgio Ciprandi, Fabio Luigi Massimo Ricciardolo   +1 more
exaly   +3 more sources